Performance & Momentum
6 Months
12.95 %
1 Year
54.55 %
3 Years
45.95 %
5 Years
69.29 %
Strategic Analysis
Johnson & Johnson holds a leading defensive position in healthcare, combining pharmaceuticals, medical devices, and consumer health products. This diversification allows it to smooth out cycles while relying on franchises with high barriers to entry and sustained innovation capabilities.
Strengths
- Diversified model that reduces dependence on any single business line and stabilizes revenue
- Brand and product portfolio benefiting from strong recognition and high regulatory barriers
- High-quality defensive profile, valued for its resilience and long-term visibility
Weaknesses
- Growth is generally more moderate than that of more specialized healthcare companies or those more exposed to disruptive innovation
- Group complexity, with several business segments that can dilute the clarity of the growth driver
Momentum
Momentum is solid and reflects a well-established upward trend, supported by a better perception of the stock across multiple time horizons. Recent dynamics suggest renewed interest in defensive quality names, with execution deemed robust enough to remain attractive in an uncertain environment.
Similar stocks to JOHNSON + JOHNSON DL 1
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
Anantys Community
0Be the first to share your analysis on JOHNSON + JOHNSON DL 1.
Log in to publish your comment
To publish your comment, you need to be signed in.